| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 1e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-05 |